Pharmacoeconomic Study Guidelines and Implementation in the Analgesic Therapeutic Class of Tangerang City Health Department Drug Formulary
Main Article Content
Abstract
The journal details the process and content of the Drug Formulary created by the Tangerang City Health Department and discusses the pharmacoeconomic approaches used in the selection of drugs based on the Pharmacoeconomic Study Guideline. The formulary consists of 36 types of drugs and is only applicable within the regional institution. The pharmacoeconomic study was conducted using a cost-effectiveness analysis method for the proposed formulary drug list in the analgesic therapy class. The therapeutic effectiveness of each drug is expressed as a percentage, calculated by dividing the number of cases for each drug by the total number of cases in 2018. The samples analyzed were ibuprofen suppositories, paracetamol suppositories, ketoprofen suppositories, ketorolac injections, and tramadol injections. The results of the pharmacoeconomic studies on analgesic drugs indicated that ibuprofen suppositories are highly effective and cost-effective. Despite this, the Tangerang City Health Department does not currently include ibuprofen suppositories in its formulary. Instead, they have chosen ketorolac for injection. However, based on the ICER calculation, it has been determined that the procurement cost of ketorolac injection exceeds RP99.19 per case compared to tramadol injection. Only ketoprofen suppositories are deemed suitable and eligible for inclusion in the Formulary. The lack of trained personnel in pharmacoeconomic studies meant that this crucial study was not considered important. This study could help identify medications that offer superior effectiveness at lower costs, thus providing substantial cost-effectiveness.
Article Details
References
[2] Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan,Pedoman Penerapan Kajian Farmakoekonomi. Jakarta: Kementerian Kesehatan RI, 2013.
[3] Kepala Dinas Kesehatan Kota Tangerang, Formularium. Tangerang: Dinas Kesehatan Kota Tangerang, 2019.
[4] Menteri Kesehatan Republik Indonesia, Pedoman Nasional Pelayanan Kedokteran Tata Laksana Nyeri. Jakarta: Kementerian Kesehatan, 2019.
[5] A.P. Rondonuwu, J. L. Rompis, and D. S. Waworuntu, “Efficacy of Paracetamol Compared to Ibuprofen on Closure of Patent Ductus Arteriosus in Premature Infants,” Jurnal Ilmiah Kedokteran Klinik, vol. 10, no. 2, pp. 190-200, 2022.
[6] D. R. Juwita, N. Faradani, and M. I. N. A. Wibowo, “Drug Utilization Studies of Analgesic for Vaginal Delivery and Cesarean Section Patients at RSU Bunda Purwokerto,” PHARMACY: Pharmaceutical Journal of Indonesia, vol. 16, no. 02, pp. 265-277, 2019.
[7] Y. B. Setyawan, and M. Rosita, “Comparison of The Level of Satisfaction With The Use of Analgesics Ketorolac 30 mg and Paracetamol 1000 mg in Moderate Post-Operative Patients,” Scientific Periodical of Public Health and Coastal, vol. 6, no. 1, pp. 190-198, 2024.
[8] Menteri Kesehatan Republik Indonesia, Harga Obat Generik. Jakarta: Kementerian Kesehatan Republik Indonesia, 2008.